The Thailand Centre of Excellence for Life Sciences (TCELS) is a non-profit organization that operates under the supervision of the Royal Thai Government. It was established on June 18, 2004 by Royal Decree of the King of Thailand. Dr Thongchai Thavichachart MD is its current President and CEO.

The focus of TCELS is to encourage investment and development of a life sciences industry in Thailand, as well as promoting life sciences research. It seeks to create partnerships with foreign investors and foster collaboration between educational institutions and the private sector.

Some examples of TCELS projects:

• The Tsunami Post Traumatic Stress Disorder (PTSD) Center
  Tsunami PTSD Center
  The Tsunami Post Traumatic Stress Disorder Center is a nonprofit institution located in Bangkok, Thailand, committed to the study, treatment and education of PTSD and related mental health issues, many of which are specific to Asia....
  
  
• The Pharmacogenomics
  Pharmacogenomics
  Pharmacogenomics is the branch of pharmacology which deals with the influence of genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with a drug's efficacy or toxicity...
  
   Project is building a database of patients with Thalassemia, diabetes, cardio vascular diseases, rheumatoid arthritis, HIV/AIDS, lupus
  Systemic lupus erythematosus
  Systemic lupus erythematosus , often abbreviated to SLE or lupus, is a systemic autoimmune disease that can affect any part of the body. As occurs in other autoimmune diseases, the immune system attacks the body's cells and tissue, resulting in inflammation and tissue damage...
  
  , Leukemia in children, DPD deficiency
  Dihydropyrimidine dehydrogenase deficiency
  Dihydropyrimidine dehydrogenase deficiency is an autosomal recessivemetabolic disorder in which there is absent or significantly decreased activity of dihydropyrimidine dehydrogenase, an enzyme involved in the metabolism of uracil and thymine.Individuals with this condition may develop...
  
  and post-traumatic stress disorder. This database will be used to investigate the influence of patients’ genetic characteristics on their response to drug treatment.